Zydus Lifesciences Ltd has launched PEPAIR™, India’s first affordable Oscillating Positive Expiratory Pressure (OPEP) device. Priced at ₹990, the handheld, drug-free respiratory tool supports patients with COPD, asthma, and bronchiectasis by improving mucus clearance and breathing. The innovation bridges accessibility gaps in airway therapy across India.
Zydus Lifesciences Ltd, an innovation-led global life sciences company, announces the launch of PEPAIR™, a breakthrough Oscillating Positive Expiratory Pressure (OPEP) device designed to aid patients suffering from chronic respiratory conditions.
The device features a unique 3-resistance system that helps clear mucus from airways, improving lung function and breathing capacity. Unlike conventional treatments, PEPAIR™ is drug-free, portable, and affordable, making it accessible to a wider patient base.
Introduced at a patient-friendly price of ₹990 per unit, the device aims to democratize respiratory care in India, where chronic respiratory diseases are on the rise. The launch is in partnership with AeroDel Technology Innovations Pvt., reinforcing Zydus’ commitment to innovation and patient-centric healthcare solutions.
Key Highlights:
-
Product Launch: PEPAIR™, India’s first affordable OPEP device.
-
Target Patients: COPD, asthma, bronchiectasis sufferers.
-
Unique Feature: 3-resistance system for effective mucus clearance.
-
Price Point: ₹990 per unit, bridging affordability gaps.
-
Strategic Impact: Expands Zydus’ respiratory care portfolio in India.
This launch strengthens Zydus Lifesciences’ position in the respiratory healthcare segment, aligning with its mission to deliver innovative, accessible, and affordable medical solutions.
Sources: Business Upturn, Zydus Lifesciences Press Release